Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS)
Clinical trial NCT03068754 · TERMINATED
Trial details
- NCT number
- NCT03068754
- Sponsor
- Mallinckrodt
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-22
- Primary completion
- 2019-11-25
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.